Portfolio company Inno4Life sold to the Swiss company Dec Group

Portfolio company Inno4Life sold to the Swiss company Dec Group

Amsterdam, April 16, 2020 – Earlier this month, Inno4Life, a manufacturer of machines for the pharmaceutical industry, was sold to the Swiss Dec Group. Inno4Life’s management will remain actively involved in the company after its acquisition, which will continue to operate under its own name.

Inno4Life is an innovative manufacturer of complex filling and packaging machines for the pharmaceutical industry. The company distinguishes itself through its extensive knowledge and experience and the delivery of tailor-made solutions to its customers. Its customers include leading pharmaceutical companies.

International growth ambitions
To enable further international growth, Inno4Life has searched for a strong partner and found this partner in Dec Group.

Johan Klootwijk, co-founder and Managing Director of Inno4Life, commented: “Dec’s acquisition provides a major growth opportunity for both our businesses through an enhanced service offering for our clients. We will be best positioned to offer outstanding quality solutions and increased effectiveness as a result of combined action and co-operation.”

Jan-Frens van Giessel, healthcare partner at Holland Capital, is also pleased with the acquisition: “Inno4Life has gained a strong position within the pharmaceutical industry. The acquisition by Dec is a logical next step, that enables Inno4Life continuing their international expansion. We wish Inno4Life and Dec a successful joint future.”

About Holland Capital
Over the past 38 years, Holland Capital has invested successfully in over 140 small and medium-sized enterprises in the Netherlands. With a clear investment strategy, it focuses its activities in the attractive growth markets of Healthcare and Tech. Holland Capital’s experienced and dedicated investment team knows what doing business means. They strive for an open, long-term and professional relationship with the management teams of the enterprises Holland Capital invests in, with the shared goal of achieving growth. Holland Capital is supported by a broad network of successful businesses in Healthcare and Tech.

About Dec
Dec is a leading global provider of contained powder handling systems and is recognized as a world-leading expert in process containment technologies. It has been supplying the pharmaceutical, chemical, food and cosmetic industries for more than 30 years. Headquartered in Switzerland, Dec has a global presence in more than 30 countries. In excess of 600 companies worldwide have successfully integrated more than 9000 Dec systems into their production sites. These include a wide range of patented products that enhance safety, hygiene, containment, reliability and productivity in powder handling.